March 21, 2026 — RNews

#drug efficacy — Saturday, March 21, 2026 (1 items)

hot top new

← prev day next day →

0

Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial. (linkinghub.elsevier.com)

Rosenstock J … Zhao Y The Lancet 2026-03-21

#clinical trial #diabetes #drug efficacy #glp-1 agonist